Purchase Order W81K0018P0449
Award Date 8/28/18
Potential Completion Date 9/30/19
Potential Value $208K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78234, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Lantheus Medical Imaging, Inc. for the delivery of DEFINITY (PERFLUTREN LIPID MICROSPHERES), a cardiovascular contrast agent used to enhance echocardiogram imaging. The one-year contract with a potential value of $107,145.60 was awarded on October 1, 2019, with a completion date of September 30, 2020. Lantheus Medical Imaging, a manufacturer of diagnostic medical imaging agents and products, has...
- The Department of the Army Medical Command awarded a $588,085.10 firm fixed price purchase order to Lantheus Medical Imaging, Inc. for DEFINITY (PERFLUTREN LIPID MICROSPHERES). Performance will occur in San Antonio, TX and extend through September 30, 2024. Lantheus Medical Imaging, Inc. is a for-profit manufacturer of goods and subsidiary of Lantheus Holdings, Inc. No set-aside designation was applied to this contract to deliver an ultrasound contrast agent used in echocardiograms to evaluate...
- This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceuticals. The contract is valued at $141,137.33 and has a completion date of September 30, 2019. The contract was awarded on June 29, 2018 and is not set-aside. Lantheus Medical Imaging, a manufacturer of diagnostic medical imaging agents and products, is providing technetium-99m generators, xenon-133 gas, sestamibi vials, and...
- This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
- This is a firm fixed price delivery order awarded by the Defense Health Agency to Lantheus Medical Imaging, Inc. for the provision of injectable agents used for diagnostic imaging at Walter Reed National Military Medical Center. The order, valued at $141,524.83, was issued against Lantheus' General Services Administration Federal Supply Schedule 61-IB contract for Pharmaceuticals and Drugs. Lantheus Medical Imaging is a manufacturer of diagnostic medical imaging agents and has previously been...
- The Defense Health Agency awarded a $77,206.25 purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals on October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract, which carries no small business set-aside designation, supports medical imaging operations at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc. and based in North Billerica, Massachusetts, is a specialized manufacturer of diagnostic nuclear...
- Lantheus Medical Imaging, Inc. was awarded a $96,748.26 firm fixed price call against the Defense Health Agency's UC 180 Radiopharmaceuticals blanket purchase agreement to provide radiopharmaceutical products and services. As the prime contractor, Lantheus Medical Imaging will deliver the requested supplies from its production facility in Fort Sam Houston, Texas by September 11, 2023 in support of the Defense Health Agency's medical imaging programs. No subcontractors or set aside designations...
- This federal contract award is for the delivery of medical imaging products for nuclear medicine use at the Walter Reed National Military Medical Center. The prime contractor is Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract was awarded by the Defense Health Agency on a firm fixed price basis using Lantheus' Pharmaceuticals and Drugs Schedule contract. The potential value of the delivery order is $149,558.58, and it has a...
- This is a delivery order awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract, valued at $120,825.99, is for the delivery of TC99M LEU generators under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is the prime contractor and no set-aside was used for this award. The company has been awarded numerous...
- The Defense Health Agency awarded a $66,256.48 firm fixed price blanket purchase agreement call contract to Lantheus Medical Imaging, Inc. for the delivery of radiopharmaceuticals. As the parent company, Lantheus Holdings, Inc. oversees performance of this contract. No set-aside provisions were specified in the award. Lantheus Medical Imaging will provide the radiopharmaceutical products to the Defense Health Agency from its place of performance in Fort Sam Houston, Texas, in support of the...